260 related articles for article (PubMed ID: 34334369)
1. Membrane-Facilitated Receptor Access and Binding Mechanisms of Long-Acting
Szlenk CT; Gc JB; Natesan S
Mol Pharmacol; 2021 Oct; 100(4):406-427. PubMed ID: 34334369
[TBL] [Abstract][Full Text] [Related]
2. Salmeterol's extreme β2 selectivity is due to residues in both extracellular loops and transmembrane domains.
Baker JG; Proudman RG; Hill SJ
Mol Pharmacol; 2015 Jan; 87(1):103-20. PubMed ID: 25324048
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological similarities and differences between beta2-agonists.
Lötvall J
Respir Med; 2001 Aug; 95 Suppl B():S7-11. PubMed ID: 11534896
[TBL] [Abstract][Full Text] [Related]
4. Beta-2 Adrenergic Agonists Are Substrates and Inhibitors of Human Organic Cation Transporter 1.
Salomon JJ; Hagos Y; Petzke S; Kühne A; Gausterer JC; Hosoya K; Ehrhardt C
Mol Pharm; 2015 Aug; 12(8):2633-41. PubMed ID: 25751092
[TBL] [Abstract][Full Text] [Related]
5. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
6. An insilico approach to high altitude pulmonary edema - Molecular modeling of human beta2 adrenergic receptor and its interaction with Salmeterol & Nifedipine.
Chandramoorthi GD; Piramanayagam S; Marimuthu P
J Mol Model; 2008 Sep; 14(9):849-56. PubMed ID: 18512086
[TBL] [Abstract][Full Text] [Related]
7. Identifying ligand binding conformations of the β2-adrenergic receptor by using its agonists as computational probes.
Isin B; Estiu G; Wiest O; Oltvai ZN
PLoS One; 2012; 7(12):e50186. PubMed ID: 23300522
[TBL] [Abstract][Full Text] [Related]
8. In vitro pharmacological characterization of vilanterol, a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action.
Slack RJ; Barrett VJ; Morrison VS; Sturton RG; Emmons AJ; Ford AJ; Knowles RG
J Pharmacol Exp Ther; 2013 Jan; 344(1):218-30. PubMed ID: 23131596
[TBL] [Abstract][Full Text] [Related]
9. Interactions between β2-Adrenoceptor Ligands and Membrane: Atomic-Level Insights from Magic-Angle Spinning NMR.
Yan S; Shaw DE; Yang L; Sandham DA; Healy MP; Reilly J; Wang B
J Med Chem; 2017 Aug; 60(16):6867-6879. PubMed ID: 28703592
[TBL] [Abstract][Full Text] [Related]
10. Relaxation kinetics of formoterol and salmeterol in the guinea pig trachea in vitro.
Anderson P; Lötvall J; Lindén A
Lung; 1996; 174(3):159-70. PubMed ID: 8830192
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into binding specificity, efficacy and bias of a β
Masureel M; Zou Y; Picard LP; van der Westhuizen E; Mahoney JP; Rodrigues JPGLM; Mildorf TJ; Dror RO; Shaw DE; Bouvier M; Pardon E; Steyaert J; Sunahara RK; Weis WI; Zhang C; Kobilka BK
Nat Chem Biol; 2018 Nov; 14(11):1059-1066. PubMed ID: 30327561
[TBL] [Abstract][Full Text] [Related]
12. Kinetic analysis of drug-receptor interactions of long-acting beta2 sympathomimetics in isolated receptor membranes: evidence against prolonged effects of salmeterol and formoterol on receptor-coupled adenylyl cyclase.
Teschemacher A; Lemoine H
J Pharmacol Exp Ther; 1999 Mar; 288(3):1084-92. PubMed ID: 10027845
[TBL] [Abstract][Full Text] [Related]
13. Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization.
Moore RH; Millman EE; Godines V; Hanania NA; Tran TM; Peng H; Dickey BF; Knoll BJ; Clark RB
Am J Respir Cell Mol Biol; 2007 Feb; 36(2):254-61. PubMed ID: 16980556
[TBL] [Abstract][Full Text] [Related]
14. Long acting inhaled beta-adrenoceptor agonists the comparative pharmacology of formoterol and salmeterol.
Anderson GP
Agents Actions Suppl; 1993; 43():253-69. PubMed ID: 8103622
[TBL] [Abstract][Full Text] [Related]
15. Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms.
Cooper PR; Kurten RC; Zhang J; Nicholls DJ; Dainty IA; Panettieri RA
Br J Pharmacol; 2011 Jun; 163(3):521-32. PubMed ID: 21306583
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
Whelan CJ; Johnson M; Vardey CJ
Br J Pharmacol; 1993 Oct; 110(2):613-8. PubMed ID: 7902175
[TBL] [Abstract][Full Text] [Related]
17. Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation.
Zhu Y; Yuan Y; Xiao X; Zhang L; Guo Y; Pu X
J Mol Model; 2014 Nov; 20(11):2491. PubMed ID: 25342155
[TBL] [Abstract][Full Text] [Related]
18. Why are long-acting beta-adrenoceptor agonists long-acting?
Anderson GP; Lindén A; Rabe KF
Eur Respir J; 1994 Mar; 7(3):569-78. PubMed ID: 7912202
[TBL] [Abstract][Full Text] [Related]
19. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency.
Palmqvist M; Persson G; Lazer L; Rosenborg J; Larsson P; Lötvall J
Eur Respir J; 1997 Nov; 10(11):2484-9. PubMed ID: 9426083
[TBL] [Abstract][Full Text] [Related]
20. Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor.
January B; Seibold A; Allal C; Whaley BS; Knoll BJ; Moore RH; Dickey BF; Barber R; Clark RB
Br J Pharmacol; 1998 Feb; 123(4):701-11. PubMed ID: 9517390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
